相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。T-Cell Immune Responses and Immunological Factors Associated with Coronavirus Disease 2019 Progression as Predictors for the Severity of the Disease in Hospitalized Patients
Tannaz Abbasi-Dokht et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2023)
The probable role and therapeutic potential of the PI3K/AKT signaling pathway in SARS-CoV-2 induced coagulopathy
Mohammad Rafi Khezri et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2022)
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
Maria Sofia Basile et al.
DRUG DISCOVERY TODAY (2022)
PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
Soheila Fattahi et al.
IMMUNOLOGIC RESEARCH (2022)
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2
Guoli Shi et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
Immunouniverse of SARS-CoV-2
Dennis Jimenez et al.
IMMUNOLOGICAL MEDICINE (2022)
Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?
Simone Cristina Soares Brandao et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling
Fei Li et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
COVID-19 and cytokine storm syndrome: are there lessons from macrophage activation syndrome?
Michael J. Ombrello et al.
TRANSLATIONAL RESEARCH (2021)
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Santhamani Ramasamy et al.
CLINICAL MICROBIOLOGY REVIEWS (2021)
IL1β Promotes TMPRSS2 Expression and SARS-CoV-2 Cell Entry Through the p38 MAPK-GATA2 Axis
Chiara Cioccarelli et al.
FRONTIERS IN IMMUNOLOGY (2021)
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition
Peter J. Mullen et al.
NATURE COMMUNICATIONS (2021)
Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2
Chia-Ming Su et al.
SCIENTIFIC REPORTS (2021)
Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
Maria Clara Saad Menezes et al.
SCIENTIFIC REPORTS (2021)
CO-RADS: Coronavirus Classification Review
Diana Penha et al.
JOURNAL OF CLINICAL IMAGING SCIENCE (2021)
Coronavirus biology and replication: implications for SARS-CoV-2
Philip V'kovski et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Time Course of Lung Changes a Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19 )
Feng Pan et al.
RADIOLOGY (2020)
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Daniel Blanco-Melo et al.
CELL (2020)
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
Yunfeng Zheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
Jolanta Pamula-Pilat et al.
SCIENTIFIC REPORTS (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
From causes of aging to death from COVID-19
Mikhail V. Blagosklonny
AGING-US (2020)
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity
Inna G. Ovsyannikova et al.
IMMUNOLOGICAL REVIEWS (2020)
The molecular virology of coronaviruses
Ella Hartenian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
The changes of the peripheral CD4+lymphocytes and inflammatory cytokines in Patients with COVID-19
Hua-Bao Sun et al.
PLOS ONE (2020)
Impact of mTOR gene polymorphisms and gene-tea interaction on susceptibility to tuberculosis
Mian Wang et al.
WORLD JOURNAL OF CLINICAL CASES (2020)
Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19
Jan Brabek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
Sofia Appelberg et al.
EMERGING MICROBES & INFECTIONS (2020)
Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients
Lei Cheng et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Predicting Functional Effects of Synonymous Variants: A Systematic Review and Perspectives
Zishuo Zeng et al.
FRONTIERS IN GENETICS (2019)
Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population
Zhen Zhang et al.
SCIENTIFIC REPORTS (2017)
New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs
Lucie Pouche et al.
PHARMACOGENOMICS (2016)
Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis
Jin Zining et al.
ONCOTARGET (2016)
Associations of PI3KR1 and mTOR Polymorphisms with Esophageal Squamous Cell Carcinoma Risk and Gene-Environment Interactions in Eastern Chinese Populations
Jinhong Zhu et al.
SCIENTIFIC REPORTS (2015)
Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population
Martha L. Slattery et al.
CARCINOGENESIS (2012)
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1
Martha L. Slattery et al.
CARCINOGENESIS (2010)
Nuclear factor of activated T cells negatively regulates expression of the tumor necrosis factor receptor-related 2 gene in T cells
Woon-Ki Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2010)
Mammalian target of rapamycin (mTOR) orchestrates the defense program of innate immune cells
Frank Schmitz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)